Zalospirone

CAS No. 114298-18-9

Zalospirone( —— )

Catalog No. M36249 CAS No. 114298-18-9

Zalospirone is a 5-HT1A receptor agonist that can be used to study anxiety disorders and major depressive disorder.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 331 In Stock
10MG 451 In Stock
25MG 634 In Stock
50MG 825 In Stock
100MG 1135 In Stock
200MG 1516 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zalospirone
  • Note
    Research use only, not for human use.
  • Brief Description
    Zalospirone is a 5-HT1A receptor agonist that can be used to study anxiety disorders and major depressive disorder.
  • Description
    Zalospirone is a 5-HT1A receptor agonist that can be used to study anxiety disorders and major depressive disorder.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114298-18-9
  • Formula Weight
    419.52
  • Molecular Formula
    C24H29N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1[C@]2([C@]([C@@]3([C@@]4([C@]([C@]2(C=C3)[H])(C=C4)[H])[H])[H])(C(=O)N1CCCCN5CCN(CC5)C=6N=CC=CN6)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SR-57227

    SR-57227 is a high affinity, selective 5-HT3 receptor agonist, demonstrates anticonvulsant effects in vivo.

  • Lesopitron

    Lesopitron is an anxiolytic with pre- and postsynaptic 5-HT1A agonist activity and is more effective than 5-HT1A agonists in rat social interaction and marmoset anxiety models.

  • Tropanserin

    Tropanserin (MDL 72422) is a 5-hydroxytryptamine receptor antagonist that inhibits 5-HT3 receptor activity.Tropanserin has anxiolytic activity and is used to treat depression and cognitive disorders.